Neurcognitive outcomes in primary CNS lymphoma (PCNSL)

Neurology

Volumn 62, Issue 4, 2004, Pages 532-533

  O'Neill, Brian Patrick ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN LYMPHOMA; BRAIN RADIATION; CANCER RADIOTHERAPY; COGNITIVE DEFECT; EDITORIAL; HUMAN; NEUROTOXICITY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; AGED; CANCER INVASION; CENTRAL NERVOUS SYSTEM TUMOR; COMORBIDITY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; NOTE; PSYCHOLOGICAL ASPECT; RADIATION INJURY; SKULL IRRADIATION;

METHOTREXATE;

AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; COGNITION DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; CRANIAL IRRADIATION; HUMANS; LYMPHOMA, NON-HODGKIN; METHOTREXATE; MIDDLE AGED; NEOPLASM INVASIVENESS; RADIATION INJURIES; TREATMENT OUTCOME;

EID: 1342309533     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.62.4.532     Document Type: Editorial

References (14)

1. Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002;95: 1504-1510.
2. So NK, O'Neill BP, Frytak S, Eagan RT, Earnest FV, Lee RE. Delayed leukoencephalopathy in survivors with small cell lung cancer. Neurology 1987;37:1198-1201.
3. Hochberg FH, Slotnick B. Neuropsychologic impairment in astrocytoma survivors. Neurology 1980;30:172-177.
4. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-796.
5. Auperin A, for the Prophylactic Cranial Irradiation Overview Collaborative Group. Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. Cochrane Database of Systematic Reviews; March 2003.
6. Brown PD, Buckner JC, O'Fallon JR, et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein mini-mental state examination. J Clin Oncol 2003;21:2519-2524.
7. Barnard RO, Scott T. Patterns of proliferation in cerebral lymphoreticular tumours. Acta Neuropathol Suppl (Berl) 1975;Suppl 6:125-130.
8. O'Neill BP, Wang CH, O'Fallon JR, et al. The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group. Neuro-Oncol 1999;1:196-203.
9. Ferreri AJ, Abrey LE, Blay JY, et al. Summary statement on primary CNS lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Oncol 2003;21:2407-2414.
10. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000;18:3144-3150.
11. Lai R, Abrey LE, Rosenblum MK, DeAngelis LM. Treatment-induced leukoencephalopathy in primary CNS lymphoma: A clinical and autopsy study. Neurology 2004;62:451-456.
12. Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 2004;62:548-555.
13. Harder H, Holtel H, Bromberg JEC, et al. Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 2004;62: 544-547.
14. Davis F, DeAngelis LM. Intra-axial tumors. In: Louis DM, Posner JP (Co-Chairs). Report of the Brain Tumor Progress Review Group. National Cancer Institute/National Institute of Neurological Disorders and Stroke. November 2000. Available at: http://prg.nci.nih.gov/brain/final-report.html